NNovo Nordisk Read More Novo Nordisk’s Oral Wegovy Defies Gravity as FDA Poised to Curb Compounders2026-05-10 Novo Nordisk’s new Wegovy pill generates 2.26B DKK in Q1, double forecasts; revenue jumps 32% to 96.82B DKK.…